KFF’s post for Health Affairs Forefront reviews the implications of the first-ever Medicare drug price negotiations. These results could generate savings for the government and Medicare beneficiaries. Candidates’ viewpoints on this issue could influence upcoming elections and the future of drug price negotiations by the government.
Weight-Loss Drugs Aren’t Really About Weight
While GLP-1 drugs can aid weight loss, their high cost and side effects present challenges. The drugs could be beneficial to people with excess visceral
